The Palliative Care Clinical Studies Collaborative was established to build the evidence base for palliative medications that can improve practice, and to expend clinical trials research capacity in the area of palliative care.

The Palliative Care Clinical Studies Collaborative aims to:

  • develop a clinical research agenda to facilitate registration of palliative medications with the Therapeutics Goods Administration (TGA)
  • facilitate clinical comparison trials and pharmacological data for Pharmaceutical Benefits Advisory Committee (PBAC) submissions
  • develop national partnerships with experts in trial design, clinical collaboratives, medical device and pharmaceutical companies
  • conduct rigorous, prospective clinical studies with economic analyses to support PBAC and TGA submissions.

Collaborators

Clinical Oncological Society of Australia    European Palliative Care Research Centre    14 palliative care Services around Australia

 Key outcomes

  • funding granted by the Department of Health and Ageing
  • establishment of a Coordinating Centre for multi-centred randomised controlled trials being conducted in 14 sites around Australia
  • 6 studies open for recruitment with an additional 2 studies being developed
  • collaboration with researchers in Queensland to secure NHMRC project grant funding
  • developed infrastructure to support clinical trials in palliative care in Australia. 
  • developed a membership based governance structure open to anyone with an interest in research.

 Key contacts